Coverage
-
September 09, 2014
The Eleventh Circuit on Monday summarily denied Stiefel Laboratories Inc.'s request for an en banc review of an appellate panel's ruling affirming a $1.5 million victory for a former sales representative who says the company misled him into selling shares at an artificially low price before a merger.
3 other articles on this case.
View all »